Bb Biotech as of June 30, 2014
Portfolio Holdings for Bb Biotech
Bb Biotech holds 24 positions in its portfolio as reported in the June 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 17.2 | $362M | 4.2M | 85.88 | |
| Gilead Sciences (GILD) | 13.7 | $289M | 3.5M | 82.91 | |
| Incyte Corporation (INCY) | 11.2 | $235M | 4.2M | 56.44 | |
| ISIS Pharmaceuticals | 11.0 | $231M | 6.7M | 34.45 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 6.3 | $133M | 1.4M | 94.68 | |
| Medivation | 5.5 | $116M | 1.5M | 77.08 | |
| Alexion Pharmaceuticals | 5.4 | $114M | 727k | 156.25 | |
| Synageva Biopharma | 4.5 | $94M | 899k | 104.80 | |
| Regeneron Pharmaceuticals (REGN) | 3.1 | $66M | 233k | 282.47 | |
| Pharmacyclics | 3.1 | $66M | 732k | 89.71 | |
| Halozyme Therapeutics (HALO) | 2.7 | $58M | 5.8M | 9.88 | |
| Neurocrine Biosciences (NBIX) | 2.2 | $46M | 3.1M | 14.84 | |
| Alnylam Pharmaceuticals (ALNY) | 1.9 | $39M | 621k | 63.17 | |
| Puma Biotechnology (PBYI) | 1.8 | $38M | 577k | 66.00 | |
| ImmunoGen | 1.8 | $38M | 3.2M | 11.85 | |
| Radius Health | 1.7 | $36M | 2.7M | 13.00 | |
| Theravance | 1.3 | $28M | 933k | 29.78 | |
| Clovis Oncology | 1.1 | $23M | 558k | 41.41 | |
| Agios Pharmaceuticals (AGIO) | 1.1 | $23M | 506k | 45.82 | |
| Tesaro | 1.0 | $22M | 705k | 31.11 | |
| Infinity Pharmaceuticals (INFIQ) | 0.9 | $19M | 1.5M | 12.74 | |
| Endocyte | 0.8 | $16M | 2.5M | 6.59 | |
| Achillion Pharmaceuticals | 0.6 | $14M | 1.8M | 7.57 | |
| Cubist Pharmaceutic-cvr | 0.0 | $105k | 876k | 0.12 |
